<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo> is the second most common manifestation of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>It is found in approximately 22% of the patients with this disease </plain></SENT>
<SENT sid="2" pm="."><plain>Often it is not severe, platelet counts usually range between 50 x 10(9)/L and 150 x 10(9)/L without <z:mp ids='MP_0001914'>bleeding</z:mp> problems </plain></SENT>
<SENT sid="3" pm="."><plain>Yet, it does not protect patients against thrombotic events </plain></SENT>
<SENT sid="4" pm="."><plain>It rarely requires treatment and, due to similarities to <z:hpo ids='HP_0001973'>idiopathic thrombocytopenic purpura</z:hpo> (<z:chebi fb="0" ids="16039">ITP</z:chebi>), similar treatment rules usually apply </plain></SENT>
<SENT sid="5" pm="."><plain>In this report two patients with APS are described who presented with severe <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> that did not respond to standard treatment regimen namely <z:chebi fb="1" ids="24261">glucocorticoids</z:chebi> (GC) followed by intravenous immunoglobulin therapy (IVIG) </plain></SENT>
<SENT sid="6" pm="."><plain>Splenectomy had to be resorted to relieve the condition </plain></SENT>
</text></document>